DRMAW

Dermata Therapeutics, Inc. [DRMAW] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

DRMAW Stock Summary

In the News

DRMAW Financial details

Company Rating
-
Market Cap
1.75M
Income
-7.76M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
8
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-0.26
Forward P/E
-
PEG
0.04
P/S
-
P/B
0.29
P/C
-
P/FCF
-0.3
Quick Ratio
7.23
Current Ratio
7.99
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-3.94
EPS next Y
-
EPS next Q
-
EPS this Y
-80.82%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-98%
ROE
-101%
ROC
-1.18%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.0092-0.0092
52W High
-
52W Low
-
RSI
44
Rel Volume
-
Avg Volume
-
Volume
5.45K
Perf Week
-22.5%
Perf Month
-47.81%
Perf Quarter
-
Perf Half Y
58.16%
-
-
-
-
Beta
0.872
-
-
Volatility
0%, 0.01%
Prev Close
-11.43%
Price
0.0155
Change
-2.52%

Something similar

Top by Market Cap
Same Sector
Similar Market Cap